Will These 5 MedTech Stocks Beat Forecasts This Earnings Season?
https://www.zacks.com/stock/news/2266211/will-these-5-medtech-stocks-beat-forecasts-this-earnings-season?cid=CS-ZC-FT-analyst_blog|earnings_preview_-_esp-2266211
May 01, 2024 - Here is a sneak peek into how the five MedTech stocks, HOLX, ZBH, ILMN, TFX and BRKR, are expected to fare in their quarterly results slated to be released tomorrow.
0
Why Zimmer (ZBH) is Poised to Beat Earnings Estimates Again
https://www.zacks.com/stock/news/2263536/why-zimmer-zbh-is-poised-to-beat-earnings-estimates-again?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2263536
Apr 26, 2024 - Zimmer (ZBH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
0
SYK vs ZBH: Which Stock Looks More Promising Ahead of Q1 Earnings?
https://www.zacks.com/stock/news/2261546/syk-vs-zbh-which-stock-looks-more-promising-ahead-of-q1-earnings?cid=CS-ZC-FT-analyst_blog|investment_ideas-2261546
Apr 24, 2024 - SYK and ZBH are expected to have witnessed strong procedural volume growth across the global market in the first quarter.
0
What's in the Cards for Zimmer Biomet (ZBH) in Q1 Earnings?
https://www.zacks.com/stock/news/2258554/what-s-in-the-cards-for-zimmer-biomet-zbh-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2258554
Apr 19, 2024 - Within the Hips business, Zimmer Biomet (ZBH) is expected to have witnessed procedure volume recovery, banking on strategic product launches in the first quarter.
0
Smith+Nephew (SNN) Expands in Australia With New Alliance
https://www.zacks.com/stock/news/2253858/smith-nephew-snn-expands-in-australia-with-new-alliance?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2253858
Apr 11, 2024 - The latest partnership allows Smith+Nephew (SNN) to complement its existing implant range with the cutting-edge navigation technology of NAVBIT.
0
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term
https://www.zacks.com/stock/news/2253319/why-zimmer-biomet-zbh-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2253319
Apr 10, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
0
Tenet (THC) Divests Six Hospitals, Sustains Divestiture Spree
https://www.zacks.com/stock/news/2249369/tenet-thc-divests-six-hospitals-sustains-divestiture-spree?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2249369
Apr 02, 2024 - Tenet Healthcare (THC) completes the sale of six California hospitals, four to UCI Health and two to Adventist Health, to refine the portfolio and reduce debt burden.
0
Here's Why You Should Buy Zimmer Biomet (ZBH) Stock Now
https://www.zacks.com/stock/news/2246920/here-s-why-you-should-buy-zimmer-biomet-zbh-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2246920
Mar 27, 2024 - Investors are optimistic about Zimmer Biomet (ZBH), led by expansion in the knee business and recovery across the business.
0
Select Medical (SEM) Q4 Earnings Beat on Patient Admissions
https://www.zacks.com/stock/news/2231204/select-medical-sem-q4-earnings-beat-on-patient-admissions?cid=CS-ZC-FT-analyst_blog|earnings_article-2231204
Feb 23, 2024 - Select Medical's (SEM) Q4 results reflect strong segmental contribution, aided by higher patient days and visits. Management expects 2024 adjusted EBITDA to be $830-$880 million, up from the 2023 reported figure of $807.4 million.
0
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term
https://www.zacks.com/stock/news/2224783/why-zimmer-biomet-zbh-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2224783
Feb 12, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
0
Pages: 12
Page 1